Pharma Compliance Monitor Solicits Industry Advice from Meade

With the future of medical innovation hanging in the balance, confusion surrounding the Sunshine Act has left those in the pharmaceutical industry in need of insight as they decide how best to collaborate with physicians.  To address these concerns, the Pharmaceutical Compliance Monitor (PCM), a publication spotlighting regulatory and compliance news and developments for the pharmaceutical and biotechnology communities, sought the expertise of Thought Leader Select’s Paul Meade:

 

More Posts

Technology is Getting Smarter

By Paul Meade, Patient Engagement Lead  It has become apparent that in order for a healthcare organization to succeed, they need to be able to

Share:

Send Us A Message